AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
Status:
Recruiting
Trial end date:
2023-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to assess safety and tolerability of a single
intravenous (given through a vein) dose of the investigational retinal tracer AMDX-2011P in
patients with neurodegenerative diseases (Parkinson's disease and ALS).